This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Asthma, unspecified (mode) (more control exclusions)
ASTHMA_NAS_EXMORE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
23834
ASTHMA_NAS_EXMORE
Control definitions
Control exclude
J10_ASTHMA, ALLERG_ASTHMA, VOCALCORDDYS, I9_HEARTFAIL, J10_HYPERSPNEUMONI, ASTHMA_EXCL
Extra metadata
First used in FinnGen datafreeze
DF2
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Asthma, unspecified (mode) (more control exclusions)
based on the number of shared cases.
Broader endpoints:
- Asthma, unspecified (mode)
- Asthma (diagnoses ohter than nonallergic)
- Asthma
- Asthma (more control exclusions)
- Asthma, including avohilmo
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 23834 | 14677 | 9157 |
| Unadjusted prevalence (%) | 5.79 | 6.37 | 5.04 |
| Mean age at first event (years) | 55.65 | 53.27 | 59.48 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ASTHMA_NAS_EXMORE – Asthma, unspecified (mode) (more control exclusions)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Asthma, unspecified (mode) (more control exclusions)
↥Endpoint not on priority list, no data to show.